FI951511A - IL-10:n käyttö insuliinista riippuvan diabetes mellituksen ennaltaestoon tai hoitoon - Google Patents

IL-10:n käyttö insuliinista riippuvan diabetes mellituksen ennaltaestoon tai hoitoon Download PDF

Info

Publication number
FI951511A
FI951511A FI951511A FI951511A FI951511A FI 951511 A FI951511 A FI 951511A FI 951511 A FI951511 A FI 951511A FI 951511 A FI951511 A FI 951511A FI 951511 A FI951511 A FI 951511A
Authority
FI
Finland
Prior art keywords
insulin
prevention
treatment
diabetes mellitus
dependent diabetes
Prior art date
Application number
FI951511A
Other languages
English (en)
Swedish (sv)
Other versions
FI951511A0 (fi
Inventor
Martha W Bond
Kevin W Moore
Kenneth Pennline
Paulo J M Vieira
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of FI951511A publication Critical patent/FI951511A/fi
Publication of FI951511A0 publication Critical patent/FI951511A0/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2066—IL-10
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
FI951511A 1992-10-01 1995-03-30 IL-10:n käyttö insuliinista riippuvan diabetes mellituksen ennaltaestoon tai hoitoon FI951511A0 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US95552392A 1992-10-01 1992-10-01
PCT/US1993/009030 WO1994008606A1 (en) 1992-10-01 1993-09-28 Use of il-10 to prevent or treat insulin-dependent diabetes mellitus

Publications (2)

Publication Number Publication Date
FI951511A true FI951511A (fi) 1995-03-30
FI951511A0 FI951511A0 (fi) 1995-03-30

Family

ID=25496932

Family Applications (1)

Application Number Title Priority Date Filing Date
FI951511A FI951511A0 (fi) 1992-10-01 1995-03-30 IL-10:n käyttö insuliinista riippuvan diabetes mellituksen ennaltaestoon tai hoitoon

Country Status (24)

Country Link
EP (1) EP0662837B1 (fi)
JP (1) JP2739770B2 (fi)
KR (1) KR0166663B1 (fi)
CN (1) CN1093598A (fi)
AT (1) ATE180168T1 (fi)
AU (1) AU689448B2 (fi)
CA (1) CA2145863A1 (fi)
CZ (1) CZ286866B6 (fi)
DE (1) DE69325029T2 (fi)
DK (1) DK0662837T3 (fi)
ES (1) ES2131122T3 (fi)
FI (1) FI951511A0 (fi)
GR (1) GR3030269T3 (fi)
HK (1) HK1008812A1 (fi)
HU (1) HU217871B (fi)
IL (1) IL107153A (fi)
MX (1) MX9306043A (fi)
MY (1) MY111543A (fi)
NO (1) NO951240L (fi)
SG (1) SG48733A1 (fi)
SK (1) SK281806B6 (fi)
TW (1) TW336172B (fi)
WO (1) WO1994008606A1 (fi)
ZA (1) ZA937244B (fi)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0752879A4 (en) * 1994-04-08 1999-07-21 Brigham & Womens Hospital TREATMENT OF AUTOIMMUNE DISEASES WITH TOLERANCE INDUCING AGENTS AND / OR ORAL TH2-ENHANCING CYTOKINES
US6410008B1 (en) 1994-12-12 2002-06-25 Beth Israel Hospital Association Chimeric IL-10 proteins and uses thereof
JPH11501506A (ja) * 1994-12-12 1999-02-09 ベス イスラエル デアコネス メディカル センター キメラ型サイトカインおよびその利用
AU6763496A (en) * 1995-08-07 1997-03-05 Schering Corporation Treatment of ocular inflammatory conditions with interleukin-10
US6022536A (en) * 1995-08-09 2000-02-08 Schering Corporation Combined use of interleukin 10 and cyclosporin for immunosuppression therapy
EP0845994A1 (en) * 1995-08-09 1998-06-10 Schering Corporation Combined use of interleukin-10 and cyclosporin for immunosuppression therapy
US5939069A (en) * 1996-08-23 1999-08-17 University Of Florida Materials and methods for detection and treatment of immune system dysfunctions
WO1999006059A2 (en) * 1997-07-30 1999-02-11 Board Of Regents, The University Of Texas System Methods and compositions relating to no-mediated cytotoxicity
US6171856B1 (en) 1997-07-30 2001-01-09 Board Of Regents, The University Of Texas System Methods and compositions relating to no-mediated cytotoxicity
US6455528B1 (en) * 1997-10-14 2002-09-24 Mitsubishi Pharma Corporation Piperazine compounds and medicinal use thereof
JP2002289768A (ja) 2000-07-17 2002-10-04 Rohm Co Ltd 半導体装置およびその製法
CN100515491C (zh) * 2005-01-04 2009-07-22 健能隆医药技术（上海）有限公司 白介素-22的医药用途
WO2014098249A1 (ja) 2012-12-21 2014-06-26 国立大学法人名古屋大学 組織修復活性組成物及びその利用
CN104623637A (zh) 2013-11-07 2015-05-20 健能隆医药技术（上海）有限公司 Il-22二聚体在制备静脉注射药物中的应用
WO2017181143A1 (en) 2016-04-15 2017-10-19 Generon (Shanghai) Corporation, Ltd. Use of il-22 in treating necrotizing enterocolitis

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL94878A (en) * 1989-06-28 2003-01-12 Schering Corp Cytokine synthesis inhibitory factor, antagonists thereof and methods of using same

Also Published As

Publication number Publication date
DE69325029D1 (de) 1999-06-24
NO951240L (no) 1995-05-30
SK281806B6 (sk) 2001-08-06
CZ80495A3 (en) 1996-01-17
ATE180168T1 (de) 1999-06-15
GR3030269T3 (en) 1999-08-31
EP0662837A1 (en) 1995-07-19
EP0662837B1 (en) 1999-05-19
KR950703353A (ko) 1995-09-20
HU9500933D0 (en) 1995-05-29
AU689448B2 (en) 1998-04-02
CN1093598A (zh) 1994-10-19
ES2131122T3 (es) 1999-07-16
DE69325029T2 (de) 1999-10-07
JPH07507567A (ja) 1995-08-24
KR0166663B1 (en) 1999-01-15
DK0662837T3 (da) 1999-11-08
SK42395A3 (en) 1997-01-08
IL107153A0 (en) 1993-12-28
MX9306043A (es) 1994-04-29
AU5163593A (en) 1994-05-09
MY111543A (en) 2000-08-30
HUT71421A (en) 1995-11-28
CA2145863A1 (en) 1994-04-28
FI951511A0 (fi) 1995-03-30
IL107153A (en) 2000-07-16
WO1994008606A1 (en) 1994-04-28
TW336172B (en) 1998-07-11
JP2739770B2 (ja) 1998-04-15
HK1008812A1 (en) 1999-05-21
NO951240D0 (no) 1995-03-30
CZ286866B6 (en) 2000-07-12
HU217871B (hu) 2000-04-28
SG48733A1 (en) 1998-05-18
ZA937244B (en) 1994-06-27

Similar Documents

Publication Publication Date Title
DE122009000012I1 (de) Substituierte pyrazolyl-benzolsulfonamide zur behandlung von entzundungen.
MY104685A (en) Substituted thiazoles and their use as fungicides.
ATE148130T1 (de) Typ-iv-dipeptidyl-aminopeptidase-inhibitoren
UA34466C2 (uk) Засіб для несистемної боротьби з паразитуючими комахами
FI931708A0 (fi) Herbicida substituerade aryl-haloalkylpyrazoler
FI951511A0 (fi) IL-10:n käyttö insuliinista riippuvan diabetes mellituksen ennaltaestoon tai hoitoon
DE69109560T2 (de) Fungizide Zusammensetzung zur Behandlung von Saatgut.
ES2191292T3 (es) Compuestos antivirales poliaromaticos.
CA2043033A1 (fr) Utilisation du baclofene pour l'obtention de medicaments destines au traitement de l'angine de poitrine
NO913117D0 (no) Fremgangsmaate for behandling av benoedeleggende sykdommer.
DK0869785T3 (da) 4-Hydroxycoumarin-3-carboxyamider til behandling af ikke-insulinafhængig diabetes mellitus
DE69409961T2 (de) Triarylethylenderivate zur therapeutischen verwendung
IL105285A0 (en) Compositions for the treatment of diabetes
ITRM940140A0 (it) Procedimento e dispositivo per la produzione di potassa.
DE69113570T2 (de) Behandlungsmittel.
ITRM920002A1 (it) Procedimento per il trattamento disinquinante, di residui contenenti caprolattame.
KR900007413A (ko) 에이즈 발병방지, 치료제 및 그 치료용 조성물
UA23368A (uk) Використання (1,1-діоксотіолан-3-іл) диктіокарбамату калію як антимікробного засобу
NO905643D0 (no) Fremgangsmaate for behandling av manganslam.
GR900100297A (en) Cylinder for the treatment of furs
ATE117543T1 (de) Ophthalmisches behandlungssystem.
BG98003U (en) Medicament for the treatment of dermatomycosis
MX9203089A (es) Composicion para el tratamiento de esquisofrenia.
DE68906028D1 (de) Verwendung von acetyl-d-carnitin zur therapeutischen behandlung von glaukom.
ZA919658B (en) New use of organic compounds.